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Despite many decades of research to develop a malaria vaccine, only one vaccine
candidate has been explored in pivotal phase III clinical trials. This candidate subunit
vaccine consists of a portion of a single Plasmodium antigen, circumsporozoite protein
(CSP). This antigen was initially identified in the murine malaria model and shown to
contain an immunodominant and protective CD8+ T cell epitope specific to the H-2Kd
(BALB/c)-restricted genetic background. A high-content screen for CD8+ epitopes in
the H2Kb/Db (C57BL/6)-restricted genetic background, identified two distinct dominant
epitopes. In this study, we present a characterization of one corresponding antigen,
the Plasmodium sporozoite-specific protein S20. Plasmodium berghei S20 knockout
sporozoites and liver stages developed normally in vitro and in vivo. This potent infectivity
of s20(-) sporozoites permitted comparative analysis of knockout and wild-type
parasites in cell-based vaccination. Protective immunity of irradiation-arrested s20(-)
sporozoites in single, double and triple immunizations was similar to irradiated unaltered
sporozoites in homologous challenge experiments. These findings demonstrate the
presence of an immunogenic Plasmodium pre-erythrocytic determinant, which is not
essential for eliciting protection. Although S20 is not needed for colonization of the
mammalian host and for initiation of a blood infection, it is conserved amongst
Plasmodium species. Malarial parasites express conserved, immunogenic proteins that
are not required to establish infection but might play potential roles in diverting cellular
immune responses.
Keywords: malaria, Plasmodium, sporozoite, whole organism vaccine, antigen, CD8+ T cells, immunization, pre-
erythrocytic stage
INTRODUCTION
Sustained anti-malaria therapy, exposure prophylaxis, and vector control have resulted in stable
incidence and mortality rates in the tropics (World Health Organisation, 2020). To reduce
global malaria burden and transmission of Plasmodium parasites, access to a safe and efficacious
prophylactic vaccine will be needed. An established method to achieve lasting sterile protection
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against natural Plasmodium sporozoite infection is intravenous
administration of multiple doses of live γ-irradiation-attenuated
sporozoites (γspz) (Nussenzweig et al., 1967; Clyde et al., 1973;
Hoffman et al., 2002; Richie et al., 2015). Identification of
immunogenic antigens and immune correlates of protection
vs. sporozoite exposure remain research priorities to develop
second-generation sporozoite vaccines.
Protective sporozoite-induced immunity is achieved by
complementary humoral and cellular memory responses
(Rodrigues et al., 1993; Hafalla et al., 2011). Previous studies
using γspz vaccination in mice have revealed the pivotal role
of circulating and liver-resident CD8+ T cells in mediating
protective immunity to the pre-erythrocytic stages of the parasite
by cytolytic killing (Ferreira et al., 1986; Schofield et al., 1987;
Weiss et al., 1988; Guebre-Xabier et al., 1999; Krzych et al., 2000;
Schmidt et al., 2008). Antigen-specific, cytolytic CD8+ T cells
target infected hepatocytes, which present MHC I-restricted
parasite peptides on the cell surface (Romero et al., 1989;
Rodrigues et al., 1991). Upon peptide recognition by CD8+ T
cells, cytokines such as interferon-γ (IFNγ) (Schofield et al.,
1987) and tumor necrosis factor (TNF) (Butler et al., 2010;
Depinay et al., 2011) are released along with pro-apoptotic
pore-forming lytic proteins, perforin and granzymes. The central
role of CD8+ T cells in pre-erythrocytic stage immunity has
been further highlighted by several studies, where abrogation of
immunity in γspz-immunized mice and non-human primates
was observed after in vivo depletion of CD8+ T cells (Schofield
et al., 1987; Weiss et al., 1988; Doolan and Hoffman, 2000;
Weiss and Jiang, 2012). CD8+ T cells, however, are less likely
to confer protection during the asexual parasite growth inside
erythrocytes, simply because MHC I molecules are not found
on the surface of mammalian erythrocytes. Accordingly, the
key role of cytolytic CD8+ T cells in sustained protection
is largely restricted to the first obligate parasite expansion
phase in the liver.
Despite decades of considerable investments in malaria
research, only one malaria vaccine has been licensed to-date,
known as the RTS,S/AS01 (RTS,S Clinical Trials Partnership,
2015; Neafsey et al., 2015). This subunit vaccine is based on
the major Plasmodium falciparum sporozoite surface antigen,
termed circumsporozoite protein (CSP) (Cohen et al., 2010). CSP
is highly conserved amongst Plasmodium species, and essential
for sporozoite formation, motility and hepatocyte adhesion.
It contains a central repeat structure, which likely further
contributes to immune-dominance over minor sporozoite
surface antigens (Zavala et al., 1983; Zavala et al., 1985). Modest
protection offered by this vaccine is strongly associated with
humoral immunity and, to a lesser extent, T-cell mediated
responses (Stoute et al., 1998; Cohen et al., 2010). Employing
murine malaria models it was shown that CSP contains
immunogenic targets of protective H2-Kd-restricted CD8+ T
cell responses that are vital for protection against sporozoite
infections (Rodrigues et al., 1991; Sedegah et al., 1992). But more
recent studies have shown that sterile protection can also be
achieved in the absence of CSP-specific T cells (Kumar et al., 2006;
Grüner et al., 2007; Gibbins et al., 2020). While these findings
might partly explain the inadequate protective efficacy of the
RTS,S/AS01 vaccine they also highlight the need to investigate
non-CSP antigens.
For the identification and evaluation of immunogenic pre-
erythrocytic stage CD8+ T cell epitopes two inbred mice strains,
H2-K/Db- and H2-Kd-restricted C57BL/6 (B6) and BALB/c
mice, respectively, have been largely used. Immunizing either
mouse strains with Plasmodium berghei (Pb) or Plasmodium
yoelii (Py) γspz is able to induce highly protective responses
(Romero et al., 1989; Rodrigues et al., 1991; Sano et al., 2001).
Candidate CD8+ T cell epitopes are typically selected based
on the amount of IFNγ from activated CD8+ T cells upon
stimulation with soluble peptides as a proxy for recognition
of immunogenic MHC I-restricted epitopes. Between the two
mouse strains, B6 mice appear to represent a more accurate
model for immunological studies as the elicited H2-Kb-restricted
CD8+ T cell responses during sporozoite infection are more
diverse. Reliance on multiple doses for protective immunity
suggest a closer resemblance to that of humans, in contrast to
the ease of eliciting protective immunity in BALB/c mice due
to the immunodominance of the CSP epitope (Hafalla et al.,
2013). Furthermore, the inability of B6 mice to recognize the H2-
Kd-restricted CSP epitope as a consequence of MHC haplotype
restriction allows identification of non-CSP-mediated immunity.
A genome-wide screening for candidate pre-erythrocytic stage
H2-K/Db-restricted CD8+ T cell epitopes in B6 mice returned
only two epitopes that correlate with protracted CD8+ T cell
responses (Hafalla et al., 2013). One H2-Db-restricted epitope
originated from the thrombospondin-related adhesion protein
(TRAP130−138) and displayed cytotoxic CD8+ T cell responses
after a single immunization with γspz. Importantly, partial
protection could be achieved by eliciting high levels of TRAP-
specific CD8+ T cells via a heterologous prime-boost regimen.
Strikingly, the other identified H2-Kb-restricted target of
CD8+ T cells (S20318−326) found in that screening, which maps
to the sporozoite-specific gene 20 (Kaiser et al., 2004), did
not induce cytotoxic immune responses. In good agreement,
tolerization with S20318−326 peptide failed to completely
reverse protection, in contrast to TRAP130−138 (Hafalla et al.,
2013). In this study, we aimed to investigate this unusual
CD8+ T cell response by generating S20 knock-out parasites
to confirm the origin of the epitope and to study potential
contributions of S20318−326 toward protection in whole
sporozoite immunizations.
RESULTS
S20 Is Highly Conserved Among
Plasmodium Species and Primarily
Expressed in Sporozoites
Since the sporozoite-specific protein S20 (PBANKA_1429200)
was first identified in Vinckeia species (Kaiser et al., 2004), we first
verified whether it is also present in other Plasmodium species
and Toxoplasma gondii. This analysis revealed S20 orthologs
in all Plasmodium species and a similar protein in T. gondii
(TGGT1_229000). Examples of representative apicomplexan S20
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FIGURE 1 | Conservation and expression of Plasmodium berghei S20. (A) Primary structure of Plasmodium and Toxoplasma S20 proteins. Predicted Kelch domains
are boxed in blue, and the position of the epitope is shown by red lines. P. berghei (PBANKA_1429200; XP_034424116.1), Plasmodium vivax (PVP01_1432200;
XP_001617233.1), P. falciparum (PF3D7_1213400; XP_001350539.1), Plasmodium malariae (PmUG01_14048200; XP_028864377.1), and Toxoplasma gondii
(TGGT1_229000; EPR64070). Accession numbers are according to EuPathDB (Aurrecoechea et al., 2017), and alignments were generated using the BLAST
algorithm (Altschul et al., 1990). (B) Detection of P. berghei S20 by indirect immunofluorescence. Shown are immune stainings of permeabilized and
non-permeabilized sporozoites, early liver stages 24 h after infection, and infected hepatoma cells 1 and 3 h after sporozoite addition. Stainings were done with an
anti-PbS20 serum, anti-PbCSP antibody, anti-PbHSP70 antibody and corresponding secondary antibodies. Shown are immune stainings and merge, including DNA
stains (Hoechst, blue) and bright field images. Scale bars, 10 µm.
orthologs are displayed in Figure 1A. S20 orthologs are also
present in other Coccidia, for instance Sarcocystis neurona
(SRCN_6348), Besnoitia besnoiti (BESB_083580), Eimeria tenella
(ETH_00029095), and Cyclospora cayetanensis (cyc_00626), but
not Piroplasms. S20 proteins contain kelch motifs, segments
of approximately 50 amino acid residues that form a single
four-stranded, antiparallel beta-sheet (Bork and Doolittle, 1994).
Kelch motifs are widely distributed in eukaryotic and prokaryotic
proteins with divergent functions. The high degree of S20 protein
sequence conservation among Plasmodium is indicative of a
possible conserved function. The sequence of H2-Kb-restricted
epitope VNYSFLYFL (Hafalla et al., 2013) is also relatively well
maintained across Plasmodium species.
We next profiled S20 expression in pre-erythrocytic stages.
In good agreement with published data (Kaiser et al., 2004), we
detected up-regulation of PbS20 mRNA in midgut and salivary
gland sporozoites (Supplementary Figure 1). As expected, the
relative transcript abundance of S20 was lower than the steady
state levels of the CSP transcripts that encode the major
sporozoite surface protein. Transcript levels dropped toward the
end of liver stage maturation and remained low during blood
infection (Supplementary Figure 1), in good agreement with the
original description (Kaiser et al., 2004).
In order to gain insights into protein expression and
localization, we generated polyclonal anti-PbS20 peptide sera.
S20 could be detected in salivary gland sporozoites and in
sporozoites that recently invaded hepatoma cells (Figure 1B).
However, 24 h after invasion, S20 was no longer detectable. The
S20 antisera could only recognize S20 in sporozoites that had
been permeabilized, which indicates that in contrast to CSP, S20
is restricted to the sporozoite interior. The specificity of the S20
signal in sporozoites was verified in immunofluorescence assays
(IFAs) using s20(-) P. berghei, where no signal was detected
(Figure 2D; see below).
Targeted Deletion of Plasmodium
berghei S20
We were interested in characterizing potential roles of PbS20
for sporozoite transmission and liver infection and to explore
the contribution of S20318−326-specific CD8+ T cell responses to
immunity elicited by whole sporozoite immunization. However,
the latter can only be tested using this strategy if s20(-)
sporozoites induce blood infections as efficiently as wild-type
(WT) sporozoites. To this end, we deleted PbS20 by double
homologous recombination to replace the open reading frame
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FIGURE 2 | Targeted gene deletion of P. berghei S20. (A) Schematic diagram of the replacement strategy to generate s20(-) parasites. After linearization with SacII
and KpnI, the replacement vector containing portions of the 5′ and 3′ flanking regions of S20 coding sequence and the Toxoplasma gondii dihydrofolate
reductase/thymidylate synthase (Tgdhfr/ts) selectable marker was transfected into P. berghei ANKA wild-type parasites. (B) Diagnostic PCR to confirm successful
replacement of the S20 genomic locus with the positive selection marker in s20(-) parasites. Shown are the results from clone 3 and 4. 5′- and 3′-integration-specific
primer combinations (5′ INT and 3′ INT) amplify the predicted fragment only in the recombinant locus. Wild-type-specific primer pairs (wt) do not produce a PCR
fragment in the recombinant locus confirming absence of residual WT parasites. (C) Verification of absence of S20 transcripts in s20(-) clones 3 and 4 salivary gland
sporozoites by RT-PCR. Note that s20 mRNA (top) is only detectable in WT sporozoites. CSP mRNA (bottom) serves as positive control. (D) Indirect
immunofluorescent stainings of permeabilized infected hepatoma cells 1 h after s20(-) (top) or WT (bottom) sporozoite addition. Stainings were done with anti-GFP
antibody, an anti-PbS20 serum, and corresponding secondary antibodies. Shown are immune stainings, DNA stains (Hoechst, blue) and merge images.
with the Tgdhfr/ts resistance cassette for positive selection in vivo
(Figure 2A). Successful transfection and cloning by limiting
dilution resulted in clonal s20(-) parasites. For this study, two
clonal parasite populations, termed clones 3 and 4, were obtained
after two independent transfection experiments. Genotyping by
diagnostic PCR verified the desired gene deletion and absence
of WT parasites from the clonal lines (Figure 2B). Additional
confirmation of the absence of S20 was obtained by RT-PCR
from total RNA isolated from s20(-) and WT salivary gland
sporozoites (Figure 2C). In contrast to CSP control transcripts,
S20 mRNA was only present in WT, but not in s20(-) sporozoites.
As noted above, immunofluorescent staining using the polyclonal
anti-PbS20 peptide sera for WT- and s20(-)-infected hepatoma
cells showed a loss of signal in s20(-), but not WT, parasites
(Figure 2D). Because initial analysis revealed that both clonal
parasite populations are phenotypically indistinguishable, one
population (clone 4) was selected for the experiments to uncover
the roles of S20 in Plasmodium life cycle progression and
subsequently, the H2-Kb-restricted S20318−326 CD8+ T cell
epitope in vaccine-induced protection. Swift selection of asexual
s20(-) parasites corroborated the notion that S20 is not required
for Plasmodium blood infection.
s20(-) Sporozoites Display Full Infectivity
to Mice
Conservation of S20 across all Plasmodium species might indicate
critical functions during pre-erythrocytic stages. Accordingly, we
monitored life cycle progression in the mosquito vector and
during sporozoite transmission. Quantification of s20(-) midgut
oocysts and salivary gland sporozoites from infected Anopheles
mosquitoes showed no differences in comparison to WT parasites
(Supplementary Table 1).
Salivary gland sporozoites were isolated and analyzed for
their capacity to perform gliding locomotion and infect cultured
hepatoma cells and mice (Figure 3). Freshly isolated s20(-)
sporozoites displayed continuous, circular gliding locomotion on
BSA-coated glass slides similar to WT parasites (Figure 3A).
When deposited onto cultured Huh7 hepatoma cells, formation
of liver stages was indistinguishable from WT parasites,
both quantitatively and morphologically (Figures 3B,C). To
rule out any defects in sporozoite infectivity in vivo, pre-
patency, i.e., the time to detection of the first blood stage
parasite, and the course of blood infection were determined
by daily microscopic examination of blood films from B6
mice following intravenous injection of 10,000 s20(-) or
WT salivary gland sporozoites, or exposure of the mice to
bites of s20(-) or WT-infected mosquitoes (Figure 3D and
Supplementary Table 2). All mice infected with either s20(-)
or WT intravenously or by mosquito bites were blood stage-
positive on day 3 after sporozoite inoculation. No differences
in the course of blood infection between the two parasite
groups were detectable. In good agreement, quantification of
the relative liver infection load 42 h after intravenous delivery
of 10,000 sporozoites by quantitative RT-PCR (qRT-PCR)
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FIGURE 3 | Normal life cycle progression of s20(-) parasites. (A) Fluorescence micrographs of s20(-) and WT sporozoites that were permitted to glide on BSA-coated
glass slides. Sporozoites and trails are visualized with an anti-PbCSP and anti-mouse secondary antibodies. Numbers show mean percentage (±SD) of gliding
sporozoites. (B) Quantification of s20(-) and WT-infected hepatoma (Huh7) cells by fluorescence microscopy 48 h after infection. Shown are mean values (±SEM);
n = 1; n.s., non-significant (unpaired t-test). (C) Representative fluorescence images of s20(-) and WT liver stages. α-HSP70 antibody (green; parasite cytoplasm),
α-UIS4 antibody (red; parasitophorous vacuole), and Hoechst (blue; nucleic acid). Scale bars, 10 µm. (D) Blood infection after sporozoite-induced infection. B6 mice
were infected by intravenous injection of 10,000 s20(-) or WT sporozoites (n = 3 each) or mosquito bites (WT, six infected mosquitoes, n = 1; s20(-), 3 or 6 infected
mosquitoes, n = 2 each). Blood infection was monitored by daily microscopic examination of Giemsa-stained blood films. Shown are mean values (±SEM).
revealed no difference between s20(-) and WT parasites
(Supplementary Figure 2).
Together, s20(-) sporozoites displayed no apparent defects in
sporozoite, liver stage or blood stage functions, permitting its use
in immunization protocols.
Effective Immunizations With Irradiated
s20(-) Sporozoites
Intravenous immunizations with metabolically active,
irradiation-attenuated sporozoites remains the benchmark
for pre-clinical and clinical evaluation of experimental malaria
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TABLE 1 | Vaccine-induced protection against WT sporozoite challenge infections.
Immunizations1 Protected/challenged Prepatency2
3 × 10,000 WT γspz 10/10 (100%) –
3 × 10,000 s20(-) γspz 9/9 (100%) –
none 0/3 (0%) day 3
1 Immunizations were done by intravenous injection of irradiated (γ) sporozoites.
2Prepatency is defined as time to the first detection of a single blood stage parasite.
vaccines. In humans and mice, sterile protection against
sporozoite-induced infections can be routinely achieved after
multiple doses of γspz (Nussenzweig et al., 1967; Hoffman
et al., 2002, 2010). We initiated our study by immunizing
groups of mice with three doses of 10,000 γspz. Immunized
and control animals were infected by a challenge dose of
10,000 WT sporozoites 29 days after the last immunization
(Table 1). All immunized animals remained blood stage negative,
while the control animals became parasitaemia-positive 3 days
after the challenge.
In order to capture potential differences in protective efficacy
offered by s20(-) and WT γspz, we next employed a sub-
optimal immunization schedule consisting of only two doses
of 10,000 s20(-) or WT γspz, which has been demonstrated
to induce incomplete protection (Friesen and Matuschewski,
2011). Immunized mice were challenged by intravenous injection
of 10,000 WT sporozoites 35 days after the last immunization
(Figure 4A). Control mice became blood stage positive on day 3
after challenge inoculation. Challenge infections of s20(-) γspz-
immunized mice resulted in blood stage parasites in 4 of 10
immunized mice with a mean pre-patent period of 8 days,
whereas 3 of 9 WT γspz-immunized mice became positive
for blood stage parasitaemia with a mean pre-patent period
of 7 days (Figure 4A). To independently confirm the results,
we performed a second immunization experiment involving
single- and two dose-immunization schedule, and quantified
parasite loads in the liver 48 h after challenge with 10,000
WT sporozoites by qRT-PCR (Figure 4B). In this analysis
we also could not detect any differences between the relative
parasite loads in livers of s20(-) and WT γspz-immunized mice.
Together, these findings suggest that the S20318−326 reactive
CD8+ T cell population does not contribute markedly to vaccine-
induced protection.
Lack of S20318−326-Specific CD8+ T Cells
in s20(-) Sporozoite-Immunized Mice
Finally, we wanted to unequivocally confirm that the cells in
immunized mice that recognize the S20 peptide VNYSFLYLF
were stimulated by this epitope in PbS20. Therefore, we
performed fluorescence-activated cell sorting (FACS) analysis
and ELISPOT assays to detect restimulated peptide-specific
splenic CD8+ T cells from γspz-immunized mice (Figure 5 and
Supplementary Figure 3). As expected, only background signals
of IFNγ responses after stimulation with S20318−326 peptide
were detected in naive and s20(-)-immunized mice (Hafalla
et al., 2013; Müller et al., 2017). In contrast, activated splenic
CD8+ T cells from WT-immunized mice could be restimulated
with S20318−326 peptide. The cell population responding to
the TRAP130−138 peptide was noticeably higher, as observed in
both WT- and s20(-)-immunized mice. As controls, we included
cells from naive B6 mice (Supplementary Figure 4). Together,
FIGURE 4 | Loss of S20 does not affect vaccine-induced protection. (A) Immunization and challenge protocol. Groups of B6 mice were immunized twice with
10,000 s20(-) (n = 10) or WT γ-sporozoites (n = 9) and challenged 35 days after the last immunization by intravenous injection of 10,000 WT sporozoites. Naïve mice
(n = 5) served as a control. Shown is a Kaplan-Meier analysis of time to blood infection after challenge infection. From day 3 onward mice were monitored daily for
blood stage parasitaemia by microscopic examination of Giemsa-stained blood films. n.s., non-significant; *p < 0.05 (Mann Whitney U test). (B) Protective efficacy
as measured by qRT-PCR. S20(-) and WT single or double immunized were challenged with 10,000 infectious sporozoites (n = 5 each). Naive mice (n = 4) served as
controls. The relative liver load was determined 42 h later after liver removal, RNA extraction and qRT-PCR with Pb18S rRNA primers normalized to mouse GAPDH.
Shown are mean values (±SEM); n = 1.
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FIGURE 5 | Absence of S20318-326-specific splenic CD8+ T cells in s20(-)-immunized mice. B6 mice were immunized once (1◦; n = 5 each) or twice (2◦; n = 3 each)
with s20(-) (red) or WT (black) attenuated sporozoites. Peptide-specific splenic CD8+ T cell responses were quantified after restimulation by intracellular staining 11
or 7 days later, respectively. (A) Representative FACS plots showing the gating strategy to identify IFNγ-secreting CD11a+ CD3+ CD8+ T cells. The percentage of
activated IFNγ+ CD8+ T cells among total CD8+ T cells after stimulation with either S20318-326 (red), TRAP130-138 (blue), or unrelated OVA258-265 (gray) peptide is
indicated. (B) Quantification of activated, IFNγ+ CD11a+ CD8+ T cells among total CD8+ T cells after stimulation with either S20318-326 (red), TRAP130-138 (blue), or
unrelated OVA258-265 (gray) peptide. Shown are mean percentage (±SEM), n = 1. Striped lines represent baseline responses from peptide-restimulated splenic cells
of naïve mice. n.s.,non-significant; **p < 0.01; ***p < 0.001 (Unpaired t-test).
these results show that the S20318−326 specific responses can
be attributed to the presence of PbS20 in sporozoites used
for immunization.
DISCUSSION
In this study, we deleted a previously identified CD8+ T
cell reactive epitope together with its corresponding gene,
the sporozoite-specific protein S20 (PBANKA_1429200) (Kaiser
et al., 2004; Hafalla et al., 2013; Müller et al., 2017).
Validating candidate antigens recognized by CD8+ T cells is an
important aspect toward a mechanistic understanding of immune
responses. As an example, previous work on identification
of reactive CD8+ T cells in a transgenic mouse model, so
called Pb T-1 cells, erroneously assigned the reactive peptide
to PBANKA_0714500 (Lau et al., 2014) to later correct this
to the ribosomal protein RPL6 (Valencia-Hernandez et al.,
2020). Here, we could assign the CD8+ T cell-reactive, H2-
Kb-restricted epitope VNYSFLYFL to P. berghei S20. Since
we also wanted to explore the cellular function of PbS20
we employed double homologous recombination to delete the
entire gene locus. We could show that s20(-) parasites progress
normally through the P. berghei life cycle and induce typical
exponential blood infections when animals are inoculated with
s20(-) sporozoites. This was surprising considering the degree
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of conservation of S20 across the genus Plasmodium. The
WT-like sporozoite signatures, including gliding motility, liver
infectivity, and prepatency permitted us to directly compare
vaccine efficacy of s20(-) γspz in comparison to WT γspz.
Despite the absence of S20318−326-reactive, IFNγ-secreting
CD8+ T cells we could not detect differences in γspz-induced
protective efficacy in double or triple immunization protocols. An
attractive hypothesis is that sporozoites express the immunogenic
S20 as a decoy to divert protective immune responses from
sporozoites and developing liver stages. In support of this
notion, prior studies investigating the P. berghei S20318−326
epitope uncovered a surprising lack of in vivo cytotoxicity of
S20318−326-specific CD8+ T cells (Hafalla et al., 2013) and an
inability of S20318−326-specific responses to confer protection
in mice (Doll et al., 2016). In marked contrast, TRAP130−138-
specific CD8+ T cells are cytotoxic, and subunit immunization
strategies against PbTRAP elicit protective immunity (Hafalla
et al., 2013; Doll et al., 2016). The presence of a similar protein
in T. gondii, which however lacks the CD8+ T cell epitope
under investigation, hints at a potential alternative hypothesis.
S20 could be a remnant apicomplexan sporozoite protein, which
no longer exerts a central role in Plasmodium sporozoites.
We consider this possibility less likely due to the high degree
of conservation. Experimental genetics studies in coocidian
parasites are warranted to determine the role of the kelch-
containing proteins in these parasites and infer a potential loss
of function in Haemosporidae.
Identifying immunogenic targets of protective immunity
against Plasmodium infection remains a priority in malaria
research. Early work with γspz immunizations has established
that protracted, sterilizing pre-erythrocytic protection can be
largely attributed to memory effector CD8+ T cells (Schofield
et al., 1987; Weiss et al., 1988; Guebre-Xabier et al., 1999;
Krzych et al., 2000; Schmidt et al., 2008). However, robust
protection cannot be directly inferred from the magnitude
of epitope-specific IFNγ+ CD8+ T cell populations (Hafalla
et al., 2013; Kimura et al., 2013; Müller et al., 2021). For
instance, heterologous prime-boost immunizations with TRAP-
expressing adenovirus and Modified Vaccinia Ankara (Ad-M)
generated very high levels of TRAP130−138-reactive effector
CD8+ T cells in H2-K/Db- restricted B6 mice, but provided
only partial protection against sporozoite challenge infections
(Hafalla et al., 2013). On the other hand, rendering the
OVA258−265 model epitope poorly immunogenic by placing
it in the context of a liver stage antigen still resulted
in efficient killing of parasite-infected cells by vaccination
(Müller et al., 2021). In the H2-Kd-restricted BALB/c model
vaccine efficacy can be largely predicted by the magnitude of
CD8+ T cells reactive to the immunodominant CSP-specific
epitope (SYVPSAEQI) (Bruña-Romero et al., 2001; González-
Aseguinolaza et al., 2003). Hence, in order to design subunit
vaccine strategies that are as potent as the protracted sterile
protection induced by γspz, many factors including specificity
of CD8+ T cell responses and magnitude of responses have
to be considered.
To date, most targets of γspz-induced CD8+ T cells are
likely either poorly defined or remain unrecognized, and whether
γspz-induced protection requires presentation of many or just
a few pre-erythrocytic stage epitopes remains unclear. Previous
work has focused on identifying and investigating individual
CD8+ T cell epitopes using subunit vaccine strategies (Bruña-
Romero et al., 2001; Hafalla et al., 2013; Doll et al., 2016),
but the reverse approach, to test whether individual epitopes
are required for sterile immunity offered by γspz, remains
largely unexplored. Previous studies have demonstrated the
ability to elicit sterile immunity in H-2Kd-restricted BALB/c
mice in the absence of CSP-specific responses (Grüner et al.,
2007; Gibbins et al., 2020). The findings suggested that sterile
protection does not necessarily depend on CSP-reactive CD8+
T cells, and indicated that inclusion of additional, non-CSP
epitopes to subunit vaccine strategies is warranted. Another
important stepping stone toward a better understanding of
the underlying mechanisms of vaccine-induced protection
is distinction of protective from non-protective epitopes by
experimental genetics, as exemplified in this study.
Sterile immunity offered by γspz in the absence of S20 clearly
suggests that S20 is not a promising malaria vaccine candidate,
fully supporting the findings that prime-boost immunization
against S20318−326 epitope in mice did not elicit sterilizing
immunity despite robust CD8+ T cell responses (Doll et al.,
2016). For viral infections, compensatory CD8+ T cell responses
were shown to be induced by subdominant epitopes when
immunodominant epitope-specific effector CD8+ T cells are
absent (Rodriguez et al., 2002; van der Most et al., 2003).
Apparently, immunosuppressive effects of IFNγ secreted in large
amounts by dominant CD8+ T cell responses are abolished, thus
allowing subdominant epitope-specific precursor CD8+ T cells
to proliferate. As a result, the subdominance is alleviated and
compensatory responses are generated without suppression by
IFNγ. Therefore, IFNγ plays a vital role in shaping the epitope
immunodominance hierarchy, and subdominant epitopes are
key players in inducing these compensatory responses in the
absence of immunodominant epitopes. Together, the absence
of the subdominant S20318−326 epitope in P. berghei, as
demonstrated by inferior IFNγ responses in comparison to
TRAP130−138, apparently did not result in compensatory
responses generated toward other CD8+ T cell epitopes. Hence,
maintenance of sterile protection observed in the absence of
S20-specific responses was achieved by the sum of all γspz-
induced responses other than S20318−326. This hypothesis
can be experimentally addressed by a similar strategy as
presented herein, by removal of the dominant H2-Db-restricted
TRAP130−138 CD8+ T cell epitope.
The anti-PbS20 peptide antiserum detected a cytoplasmic
location of S20 in sporozoites and very early liver stages.
The effect of antigen localization on protective immunity
was also examined with the model antigen ovalbumin
(OVA) in transgenic P. berghei-expressing exported or non-
exported OVA (Montagna et al., 2014). P. berghei parasites
expressing secreted OVA were found to enhance CD8+
T cell proliferation and MHC I presentation by infected
hepatocytes during immunization, resulting in improved
liver stage clearance following homologous sporozoite
challenge. Importantly, large differences in immunogenicity
Frontiers in Microbiology | www.frontiersin.org 8 August 2021 | Volume 12 | Article 703804
fmicb-12-703804 August 2, 2021 Time: 13:31 # 9
Hon et al. Plasmodium S20 as Immune Decoy
due to antigen origin in malaria pre−erythrocytic stages
are overcome by robust recognition by vaccine−induced,
antigen-specific effector CD8+ T cells, leading to comparable
high levels of protection (Müller et al., 2021). Hence, although
intracellular antigens might have marginal impacts on the level
of CD8+ T cell responses to whole sporozoite immunization,
immunogenic CD8+ T cell epitopes derived from intracellular
proteins should not be disregarded as potential candidates in
subunit vaccine design.
In conclusion, our results revealed a non-vital role of S20
in Plasmodium life cycle progression in vivo and surrogate cell
culture assays, despite being a highly conserved gene across
all Plasmodium species. Protective immunity from s20(-) γspz
immunizations was similar to WT γspz. Our findings exemplify
that malarial parasites express conserved, immunogenic
proteins that are not required to establish infection in a new
mammalian host but might play potential roles in diverting
cellular immune responses. Molecular and immunological
characterization of candidate Plasmodium antigens can assist in




All animal work was conducted in accordance with the German
“Tierschutzgesetz in der Fassung vom 18. Mai 2006 (BGBl. I
S. 1207),” which implements the directive 86/609/EEC from
the European Union and the European Convention for the
protection of vertebrate animals used for experimental and other
scientific purposes. The ethics committee of MPI-IB and the
Berlin state authorities (LAGeSo Reg# G0469/09 and G0294/15)
approved the protocol.
Parasites and Experimental Animals
Plasmodium berghei ANKA cl507 parasites that constitutively
express GFP under the PbEF1α promoter were used in
our experiments (Franke-Fayard et al., 2004). Six- to
Eight-weeks old female NMRI and SWISS or B6 mice
used in this study were either purchased from Charles
River Laboratories or bred in-house. NMRI mice were
used for transfection experiments, blood stage infections
and transmission to Anopheles stephensi mosquitos. B6
mice were used for sporozoite infections and subsequent
immunological studies.
Targeted Gene Deletion and Expression
of S20
The P. berghei S20 gene was deleted by a double homologous
recombination strategy using a standard replacement knockout
plasmid (pB3D; van Dijk et al., 1995). For this aim, fragments
from the 5′ and 3′ ends were amplified with primers S20SacII and
S20NotI, and with the primer pair S20HindIII and S20KpnI using
PCR. Subsequently, the 5′ PCR fragment was double digested
overnight at 37◦C with the restriction enzymes SacII and NotI,
while the restriction enzymes HindIII and KpnI were used for
the 3′ fragment digestion. 10 µg plasmid was linearized with
SacII and KpnI for transfection. Transfection experiments were
carried out twice, as previously described (Janse et al., 2006),
to obtain two independent clones for phenotypical analysis;
clone 3 and 4. Successful integration was tested on genomic
DNA by conventional PCR using the primers Test1S20fw and
JFUTRrv for 5′ integration, and TgPro and Test2S20rv for 3′
integration. Absence of WT parasites in the clonal population
was verified using Test1S20fw and Test2S20rv primers. The
PCR was carried out as follows: Initial denaturation for 3 min
at 94◦C, followed by 35 cycles of 30 s denaturation at 94◦C,
annealing for 45 s at 55◦C, and extension at 60◦C for 2 min
30 s. A final extension was carried out for 10 min at 60◦C.
For studying the expression of S20 during the P. berghei life
cycle, amplification was performed by qPCR with the primers
qS20fw and qS20rv on cDNA of midgut sporozoites, salivary
gland sporozoites, early liver stages, late liver stages, mixed
blood stages and gametocytes obtained from P. berghei ANKA
cl507 parasites, which constitutively express GFP under the
PbEF1α promoter (Janse et al., 2006). Expression levels were
normalized to the GFP transcript levels determined by primers
qGFPfw and qGFPrv.
Salivary Gland Sporozoite Isolation
Wild-type GFP-expressing P. berghei ANKA and P. berghei s20(-)
strains were maintained by continuous cycling between rodent
hosts (B6 or NMRI and SWISS mice) and female A. stephensi
mosquito vectors (Vanderberg, 1975). Mosquitoes were kept
at 28◦C (non-infected) or 20◦C (infected) at 80% humidity.
After 10–14 days, midguts were isolated and oocyst development
analyzed by fluorescent microscopy. Salivary gland sporozoites
were isolated from mosquitos in DMEM medium containing 10%
fetal calf serum (FCS).
Polyclonal Anti-S20 Antibody Generation
Polyclonal antibodies against S20 were raised in rabbits
immunized with synthetic peptides (MSDISDFSDIDDFSE+C
and C+TFTSKKLTENPGKRAY) (Eurogentec, Seraing, Belgium).
Immunofluorescence Staining of Salivary
Gland Sporozoites
The gliding motility of salivary gland sporozoites was evaluated
by IFA. 5,000 WT or s20(-) salivary gland sporozoites suspended
in 3% BSA-RPMI were added into each ring of a Medco glass
slide pre-coated with 3% BSA-RPMI. The sporozoites were
incubated for 45 min at 37◦C, during which the parasites glide
and shed surface proteins into the extracellular environment. To
visualize gliding motility, sporozoites and trails of shed proteins
were stained with mouse anti-sporozoite surface antibody,
followed by anti-mouse Alexa Fluor 488-coupled antibody
(Invitrogen, Carlsbad, CA, United States) and the nuclei stain
Hoechst 33342 (Invitrogen, Carlsbad, CA, United States) Slides
were mounted with Fluoromount-G (SouthernBiotech) prior to
analysis by fluorescence microscopy using Zeiss Axio Imager
Z2. To detect S20 by immunofluorescence, sporozoites were
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fixed in 3% PFA and permeabilized as indicated with 0.3%
Triton X-100 prior to staining with custom-made anti-S20
peptide antiserum or monoclonal anti-CSP (3D11) antibody
(Yoshida et al., 1980), and Hoechst 33342 (Invitrogen, Carlsbad,
CA, United States).
Hepatoma Cell Infection in vitro and
Immunofluorescence Staining
Nunc Lab-Tek II 8-well Chamber Slides (Thermo Fisher
Scientific, New York, NY, United States) were seeded with
30,000 Huh7 cells per well 24 h before infection. 10,000 WT or
s20(-) salivary gland sporozoites suspended in 100 µl DMEM-
complete were added and allowed to settle for 1 h at RT.
P. berghei S20 was immunostained to investigate the expression
of S20 during liver stage development. Here, infected hepatoma
cells were incubated at 37◦C for 1 and 3 h after infection
prior to fixation with 4% paraformaldehyde and staining with
monoclonal anti-HSP70 antibody (Tsuji et al., 1994), anti-S20
peptide antiserum, and Hoechst 33342 (Invitrogen, Carlsbad,
CA, United States). Phenotypic analysis of parasite liver stage
development was monitored by IFA in Huh7 cells 48 h post-
infection at 37◦C. The infected cells were permeabilized with
0.2% Triton-X 100 (Roth, Karlsruhe, Germany) and analyzed
48 h later after fixation with 4% PFA by staining with mouse
anti-HSP70 antibody (Tsuji et al., 1994) followed by goat
anti-mouse Alexa Fluor 488 antibody (Invitrogen, Carlsbad,
CA, United States) and Hoechst 33342 (Invitrogen, Carlsbad,
CA, United States). Slides were mounted with Fluoromount-G
(SouthernBiotech) and imaged by fluorescence microscopy (Zeiss
Axio Imager Z2). At least 20 intracellular parasites per sample
were visualized.
s20(-) Parasite Infectivity in vivo
To determine the infectivity of sporozoites, B6 mice were
infected intravenously with either 10,000 WT or s20(-) salivary
gland sporozoites suspended in 100 µl PBS per mouse.
Simultaneously, another group of B6 mice were infected through
direct bites from WT or s20(-)-infected A. stephensi mosquitos
for 20 min. In order to confirm the number of mosquitos
that received a blood meal, the mosquitos were paralyzed
briefly at −20◦C and observed for blood in the abdomen
under a compound microscope. The pre-patent period was
determined by daily microscopic examination of Giemsa-stained
blood smears.
Quantification of Parasite Development
in vivo
To rule out a defect of s20(-) parasites during liver stage
development and to determine protective outcome of immunized
mice against homologous sporozoite challenge, P. berghei 18S
rRNA level during liver stage infection was quantified. Naïve
B6 mice were inoculated with either 10,000 WT or s20(-)
sporozoites intravenously for phenotypic characterization, and
in the sterile protection experiment, female B6 mice were
challenged with 10,000 WT sporozoites 35 days after the last
immunization. 42 h after infection, the mice were sacrificed
and livers were removed to isolate total RNA using Qiagen
RNeasy kit, followed by reverse transcription of the RNA using
RETROscript kit. Quantitative Real-Time PCR was performed
on cDNA samples using Pb18S ribosomal subunit primer
pairs (Gene ID: 160641; sense and antisense primers), mouse
GAPDH primer pairs (Gene ID: 281199965; sense primer and
antisense primers). Relative liver infection loads were then
determined using the 1Ct method as previously described
(Friesen et al., 2010).
Immunization With Attenuated WT and
s20(-) Sporozoites
Salivary gland sporozoites were attenuated either by a γ-
irradiation dose of 12 × 104 cGy, or with azithromycin
(AZ) cover (4.8 mg in 200 µl of sodium chloride solution
per mouse) (Friesen et al., 2010). For challenge experiments,
B6 mice were immunized with two and three doses of WT
and s20(-) γspz. Immunizations in the two-dose regimen
with 10,000 sporozoites were carried out on day 0 and 7.
Challenge with 10,000 sporozoites was on day 42, including an
addition of 5 age-matched naïve B6 mice. The priming dose of
the three-dose regimen consisted of 15,000 sporozoites, while
the subsequent two boosts comprised of 10,000 sporozoites.
The immunization doses were given at days 0, 35, and 55,
followed by a challenge with 10,000 WT sporozoites on day
84, including three naïve animals. All mice were checked for
parasitemia by microscopical examination of Giemsa-stained
blood smears starting at day 3 after challenge inoculation
until day 14. Those animals that remained parasitemia-free
were continuously checked for parasitemia up till 45 days
after the challenge.
Quantification of S20318−326-Specific
Splenic CD8+ T Cells in Immunized Mice
Each B6 mouse in immunological studies was immunized
intravenously with attenuated sporozoites resuspended in 1×
PBS via the lateral tail vein. FACS after restimulation and
staining was done to determine the absence of S20318−326-specific
splenic CD8+ T cell responses. B6 mice were immunized with
either a single-dose of 15,000 AZ-attenuated sporozoites, or two-
dose regimen of γspz followed by AZ-attenuated sporozoites
carried out on day 0 and 7, respectively, where each dose
consisted of 10,000 sporozoites. B6 mice used in enzyme-
linked immune absorbent spot (ELISPOT) experiments were
immunized twice with irradiated s20(-) or WT irradiated
sporozoites at days 0 and 7. Another two groups were immunized
in parallel at day 7. Sixteen days after the last immunization,
animals were challenged with 10,000 sporozoites, including five
naïve mice. 42 h after challenge mouse spleens were used
to extract CD8+ T cells and analyzed for their capacity to
induce IFNγ responses specific for S20318−326 and TRAP130−138-
specific CD8+ epitopes.
The peptides VNYSFLYLF (S20318−326), SALLNVDNL
(TRAP130−138) (Hafalla et al., 2013), and SIINFEKL
(OVA258−265) were synthesized by Peptides & Elephants
(Potsdam, Germany), and reconstituted in DMSO/water (1:1)
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at a concentration of 1 mM. Female B6 mice that received
a single-dose or prime-boost sporozoite immunization were
dissected 11 and 7 days after last immunization, respectively,
along with naïve control animals, to obtain splenic lymphocyte
cell suspension using a cell strainer. Red blood cell lysis was
then carried out with BD Pharm LyseTM lysing buffer (Becton,
Dickinson and Company, United States) as described in the
manufacturer’s protocol. In order to quantify sporozoite-
induced CD8+ T cells, the lymphocytes were restimulated
with peptides for 5–6 h in the presence of Brefeldin A
(Invitrogen, Carlsbad, CA, United States), followed by
extracellular and intracellular staining procedures specific
for CD3, CD11a, CD8a, and IFNγ using the following anti-
mouse antibodies; CD3e PE-Cy7 (eBioscience, Inc., San Diego,
CA, United States), CD8a PerCP Cy5.5 (eBioscience, Inc.,
San Diego, CA, United States), CD11a e450 (Invitrogen,
United States), and IFNγ-APC (eBioscience, Inc., San Diego,
CA, United States). The cells were analyzed using a BD LSR
Fortessa flow cytometer (Becton, Dickinson and Company,
United States) and data analysis was performed on FLOWJO
software (Becton, Dickinson and Company, United States).
Target CD8+ T cells were identified from the gated lymphocyte
population by the removal of doublets followed by the
exclusion of cell debris, artifacts, and other non-target cells
(Supplementary Figure 4B).
To support the findings from FACS analysis, ELISPOTs were
also carried out on splenic CD8+ T cells from immunized female
B6 mice (see above) using the same VNYSFLYLF (S20318−326)
and SALLNVDNL (TRAP130−138) (Hafalla et al., 2013) peptides
for restimulation. Sterile high protein binding Immobilon-P
MultiScreen 96-Well Plate (Millipore, Germany) with 0.45 µm
pore size were used as ELISPOT plates. Prior to plating of the
cells, plates were pre-wet for 1 min with 35% EtOH, washed
with sterile water and incubated overnight with 75 µl of rat
anti-mouse IFNγ antibody (AN-18; rat IgG1; eBioscience) at a
concentration of 8 µg/ml in sterile PBS at 4◦C. After washing
with sterile PBS, plates were blocked with DMEM containing
10% FCS and Penicillin/Streptomycin for 2 h at 37◦C. Splenic cell
suspensions from immunized and control animals were prepared
using a cell strainer, and red blood cells were lysed with BD Pharm
Lyse lysing buffer as described in the manufacturer’s protocol. 108
cells were used for isolation of CD8+ cells by positive selection
using CD8a (Ly-2) MicroBeads (Miltenyi, Germany) following
the manufacturer’s instructions. 200,000 CD8+ cells and the
same number of antigen-presenting cells were used per well.
Naïve spleen cells were incubated with 2 µM peptide for 2 h
at 37◦C. Afterward, antigen-presenting cells were γ-irradiated
for 28 min and washed twice before co-incubation for at least
20 h with CD8+ T cells at 37◦C. Plates were washed three
times with 1× PBS and three times with 1× PBS containing
0.05% Tween 20 (PBST20), and were subsequently incubated
with 100 µl PBST20 containing 0.5% FCS with 1 µg/ml of the
biotinylated detection antibody anti-mouse IFNγ mAb R4-6A2
(Mabtech, Germany) overnight at 4◦C. On the following day,
plates were washed four times in PBST20 and incubated further
for 1 h at room temperature with streptavidin-conjugated alkaline
phosphatase (BD Pharmingen, Germany) in PBST20 containing
1% FCS. After washing four times with PBST20 and 1× PBS,
ELISPOT plates were developed using the Bio-Rad AP color
development kit until spots were visible, which were then counted
using a binocular.
Statistics
Statistical analysis (see Figure Legends) were performed using
Prism software (GraphPad Software Inc., United States).
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included
in the article/Supplementary Material, further inquiries can be
directed to the corresponding author/s.
ETHICS STATEMENT
The animal study was reviewed and approved by the Ethics
Committee of MPI-IB and the Berlin state authorities (LAGeSo
Reg# G0469/09 and G0294/15) approved the protocol.
AUTHOR CONTRIBUTIONS
KMa, JF, CH, JH, and KMü designed the experiments. CH and JF
performed the experiments and analyzed the data. AI performed
and analyzed the sporozoite IFA. DS generated knockout parasite
lines. KMa, CH, and JF wrote the manuscript. All authors
commented and revised the manuscript.
FUNDING
This work was funded by the Deutsche Forschungsgemeinschaft
through the research training group–Ph.D. program 2046 “From
Experimental Models to Natural Systems” (project B1) and in part
by the Max Planck Society.
ACKNOWLEDGMENTS
We acknowledge support by the German Research Foundation
(DFG) and the Open Access Publication Fund of Humboldt-
Universität zu Berlin.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fmicb.2021.
703804/full#supplementary-material
Frontiers in Microbiology | www.frontiersin.org 11 August 2021 | Volume 12 | Article 703804
fmicb-12-703804 August 2, 2021 Time: 13:31 # 12
Hon et al. Plasmodium S20 as Immune Decoy
REFERENCES
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic
local alignment search tool. J. Mol. Biol. 215, 403–410. doi: 10.1016/S0022-
2836(05)80360-2
Aurrecoechea, C., Barreto, A., Basenko, E. Y., Brestelli, J., Brunk, B. P., Cade, S.,
et al. (2017). EuPathDB: the eukaryotic pathogen genomics database resource.
Nucl. Acids Res. 45 (D1), D581–D591. doi: 10.1093/nar/gkw1105
Bork, P., and Doolittle, R. F. (1994). Drosophila kelch motif is derived from a
common enzyme fold. J. Mol. Biol. 236, 1277–1282. doi: 10.1016/0022-2836(94)
90056-6
Bruña-Romero, O., González-Aseguinolaza, G., Hafalla, J. C. R., Tsuji, M., and
Nussenzweig, R. S. (2001). Complete, long-lasting protection against malaria
of mice primed and boosted with two distinct viral vectors expressing the
same plasmodial antigen. Proc. Natl. Acad. Sci. U.S.A. 98, 11491–11496. doi:
10.1073/pnas.191380898
Butler, N. S., Schmidt, N. W., and Harty, J. T. (2010). Differential effector pathways
regulate memory CD8 T cell immunity against Plasmodium berghei versus P.
yoelii sporozoites. J. Immunol. 184, 2528–2538. doi: 10.4049/jimmunol.0903529
Clyde, D. F., Most, H., McCarthy, V. C., and Vanderberg, J. P. (1973).
Immunization of man against sporozoite-induced falciparum malaria. Am. J.
Med. Sci. 266, 169–177. doi: 10.1097/00000441-197309000-00002
Cohen, J., Nussenzweig, V., Nussenzweig, R., Vekemans, J., and Leach, A. (2010).
From the circumspo-rozoite protein to the RTS, S/AS candidate vaccine. Hum.
Vaccin. 6, 90–96. doi: 10.4161/hv.6.1.9677
Depinay, N., Franetich, J. F., Grüner, A. C., Mauduit, M., Chavatte, J. M., Luty,
A. J. F., et al. (2011). Inhibitory effect of TNF-α on malaria pre-erythrocytic
stage development: Influence of host hepato-cyte/parasite combinations. PLoS
One 6:e17464. doi: 10.1371/journal.pone.0017464
Doll, K. L., Pewe, L. L., Kurup, S. P., and Harty, J. T. (2016). Discriminating
protective from non-protective Plasmodium-specific CD8+ T cell responses.
J. Immunol. 196, 4253–4262. doi: 10.4049/jimmunol.1600155
Doolan, D. L., and Hoffman, S. L. (2000). The complexity of protective
immunity against liver-stage ma-laria. J. Immunol. 165, 1453–1462. doi: 10.
4049/jimmunol.165.3.1453
Ferreira, A., Schofield, L., Enea, V., Schellekens, H., van der Meide, P., Collins, W.,
et al. (1986). Inhibition of development of exoerythrocytic forms of malaria
parasites by gamma-interferon. Science 232, 881–884. doi: 10.1126/science.
3085218
Franke-Fayard, B., Trueman, H., Ramesar, J., Mendoza, J., van der Keur, M., van der
Linden, R., et al. (2004). A Plasmodium berghei reference line that constitutively
expresses GFP at a high level throughout the complete life cycle. Mol. Biochem.
Parasitol. 137, 23–33. doi: 10.1016/j.molbiopara.2004.04.007
Friesen, J., and Matuschewski, K. (2011). Comparative efficacy of pre-erythrocytic
whole organism vaccine strategies against the malaria parasite. Vaccine 29,
7002–7008. doi: 10.1016/j.vaccine.2011.07.034
Friesen, J., Silvie, O., Putrianti, E. D., Hafalla, J. C. R., Matuschewski, K., and
Borrmann, S. (2010). Natural immunization against malaria: causal prophylaxis
with antibiotics. Sci. Transl. Med. 2:ra49. doi: 10.1126/scitranslmed.3001058
Gibbins, M. P., Müller, K., Glover, M., Liu, J., Putrianti, E. D., Bauza, K.,
et al. (2020). Importance of the immunodominant CD8+ T cell epitope of
Plasmodium berghei circumsporozoite protein in parasite- and vaccine-induced
protection. Infect. Immun. 88, e383–20. doi: 10.1128/IAI.00383-20
González-Aseguinolaza, G., Nakaya, Y., Molano, A., Dy, E., Esteban, M.,
Rodríguez, D., et al. (2003). Induction of protective immunity against malaria
by priming-boosting immunization with recombinant cold-adapted influenza
and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived
from the circumsporozoite protein of Plasmodium yoelii. J. Virol. 77, 11859–
11866. doi: 10.1128/jvi.77.21.11859-11866.2003
Grüner, A. C., Mauduit, M., Tewari, R., Romero, J. F., Depinay, N., Kayibanda,
M., et al. (2007). Sterile protection against malaria is independent of immune
responses to the circumsporozoite protein. PLoS One 2:e1371. doi: 10.1371/
journal.pone.0001371
Guebre-Xabier, M., Schwenk, R., and Krzych, U. (1999). Memory phenotype CD8+
T cells persist in livers of mice protected against malaria by immunization with
attenuated Plasmodium berghei sporozoites. Eur. J. Immunol. 29, 3978–3986.
doi: 10.1002/(sici)1521-4141(199912)29:12<3978::aid-immu3978>3.0.co;2-0
Hafalla, J. C., Silvie, O., and Matuschewski, K. (2011). Cell biology and immunology
of malaria. Immunol. Rev. 240, 297–316. doi: 10.1111/j.1600-065X.2010.
00988.x
Hafalla, J. C. R., Bauza, K., Friesen, J., Gonzalez-Aseguinolaza, G., Hill, A. V. S.,
and Matuschewski, K. (2013). Identification of targets of CD8+ T cell responses
to malaria liver stages by genome-wide epitope profiling. PLoS Pathogens
9:e1003303. doi: 10.1371/journal.ppat.1003303
Hoffman, S. L., Billingsley, P. F., James, E., Richman, A., Loyevsky, M., Li, T.,
et al. (2010). Development of a metabolically active, non-replicating sporozoite
vaccine to prevent Plasmodium falciparum malaria. Hum. Vaccin. 6, 97–106.
doi: 10.4161/hv.6.1.10396
Hoffman, S. L., Goh, L. M., Luke, T. C., Schneider, I., Le, T. P., Doolan, D. L.,
et al. (2002). Protection of humans against malaria by immunization with
radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185,
1155–1164.
Janse, C. J., Franke-Fayard, B., Mair, G. R., Ramesar, J., Thiel, C., Engelmann,
S., et al. (2006). High efficiency transfection of Plasmodium berghei facilitates
novel selection procedures. Mol. Biochem. Parasitol. 145, 60–70. doi: 10.1016/j.
molbiopara.2005.09.007
Kaiser, K., Matuschewski, K., Camargo, N., Ross, J., and Kappe, S. H. (2004).
Differential transcriptome profiling identifies Plasmodium genes encoding pre-
erythrocytic stage-specific proteins. Mol. Microbiol. 51, 1221–1232. doi: 10.
1046/j.1365-2958.2003.03909.x
Kimura, K., Kimura, D., Matsushima, Y., Miyakoda, M., Honma, K., Yuda, M., et al.
(2013). CD8+ T cells specific for a malaria cytoplasmic antigen form clusters
around infected hepatocytes and are protective at the liver stage of infection.
Infect. Immun. 81, 3825–3834. doi: 10.1128/IAI.00570-13
Krzych, U., Schwenk, R., Guebre-Xabier, M., Sun, P., Palmer, D., White, K., et al.
(2000). The role of intrahepatic lymphocytes in mediating protective immunity
by attenuated Plasmodium berghei sporozoites. Immunol. Rev. 174, 123–134.
doi: 10.1034/j.1600-0528.2002.00013h.x
Kumar, K. A., Sano, G., Boscardin, S., Nussenzweig, R. S., Nussenzweig, M. C.,
Zavala, F., et al. (2006). The circumsporozoite protein is an immunodominant
protective antigen in irradiated sporozoites. Nature 444, 937–940. doi: 10.1038/
nature05361
Lau, L. S., Fernandez-Ruiz, D., Mollard, V., Sturm, A., Neller, M. A., Cozijnsen, A.,
et al. (2014). CD8+ T cells from a novel T cell receptor transgenic mouse induce
liver-stage immunity that can be boosted by blood-stage infection in rodent
malaria. PLoS Pathogens 10:e1004135. doi: 10.1371/journal.ppat.1004135
Montagna, G. N., Beigier-Bompadre, M., Becker, M., Kroczek, R. A., Kaufmann,
S. H. E., and Matuschewski, K. (2014). Antigen export during liver infection
of the malaria parasite augments protective immunity. mBio 5:e1321–14. doi:
10.1128/mBio.01321-14
Müller, K., Gibbins, M. P., Matuschewski, K., and Hafalla, J. C. R. (2017). Evidence
of cross-stage CD8+ T cell epitopes in malaria pre-erythrocytic and blood stage
infections. Parasite Immunol. 39:e12434. doi: 10.1111/pim.12434
Müller, K., Gibbins, M. P., Roberts, M., Reyes−Sandoval, A., Hill, A. V. S., Draper,
S. J., et al. (2021). Low immunogenicity of malaria pre−erythrocytic stages
can be overcome by vaccination. EMBO Mol. Med. 13:e13390. doi: 10.15252/
emmm.202013390
Neafsey, D. E., Juraska, M., Bedford, T., Benkeser, D., Valim, C., Griggs, A., et al.
(2015). Genetic diversity and protective efficacy of the RTS,S/AS01 malaria
vaccine. N. Engl. J. Med. 373, 2025–2037. doi: 10.1056/nejmoa1505819
Nussenzweig, R. S., Vanderberg, J., Most, H., and Orton, C. (1967). Protective
immunity produced by the injection of x-irradiated sporozoites of Plasmodium
berghei. Nature 216, 160–162. doi: 10.1038/216160a0
Richie, T. L., Billingsley, P. F., Sim, B. K. L., James, E. R., Chakravarty, S., Epstein,
J. E., et al. (2015). Progress with Plasmodium falciparum sporozoite (PfSPZ)-
based malaria vaccines. Vaccine 33, 7452–7461. doi: 10.1016/j.vaccine.2015.09.
096
Rodrigues, M., Nussenzweig, R. S., and Zavala, F. (1993). The relative contribution
of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against
malaria. Immunology 80, 1–5.
Rodrigues, M. M., Cordey, A. S., Arreaza, G., Corradin, G., Romero, P., Maryanski,
J. L., et al. (1991). CD8+ cytolytic T cell clones derived against the Plasmodium
yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3, 579–
585. doi: 10.1093/intimm/3.6.579
Frontiers in Microbiology | www.frontiersin.org 12 August 2021 | Volume 12 | Article 703804
fmicb-12-703804 August 2, 2021 Time: 13:31 # 13
Hon et al. Plasmodium S20 as Immune Decoy
Rodriguez, F., Harkins, S., Slifka, M. K., and Whitton, J. L. (2002).
Immunodominance in virus-induced CD8+ T-cell responses is dramatically
modified by DNA immunization and is regulated by gamma interferon. J. Virol.
76, 4251–4259. doi: 10.1128/jvi.76.9.4251-4259.2002
Romero, P., Maryanski, J. L., Corradin, G., Nussenzweig, R. S., Nussenzweig, V.,
and Zavala, F. (1989). Cloned cytotoxic T cells recognize an epitope in the
circumsporozoite protein and protect against malaria. Nature 341, 323–326.
doi: 10.1038/341323a0
RTS,S Clinical Trials Partnership (2015). Efficacy and safety of RTS,S/AS01 malaria
vaccine with or without a booster dose in infants and children in Africa: final
results of a phase 3, individually randomized, controlled trial. Lancet 386,
31–45. doi: 10.1016/S0140-6736(15)60721-8
Sano, G. I., Hafalla, J. C. R., Morrot, A., Abe, R., Lafaille, J. J., and Zavala, F. (2001).
Swift development of protective effector functions in naive CD8+ T cells against
malaria liver stages. J. Exp. Med. 194, 173–180. doi: 10.1084/jem.194.2.173
Schmidt, N. W., Podyminogin, R. L., Butler, N. S., Baovinac, V. P., Tucker, B. J.,
Bahjat, K. S., et al. (2008). Memory CD8 T cell responses exceeding a large but
definable threshold provide long-term immunity to malaria. Proc. Natl. Acad.
Sci. U.S.A. 105, 14017–14022. doi: 10.1073/pnas.0805452105
Schofield, L., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R., and
Nussenzweig, V. (1987). γ interferon,CD8+ T cells and antibodies required for
immunity to malaria sporozoites. Nature 330, 664–666. doi: 10.1038/330664a0
Sedegah, M., Sim, B. K. L., Mason, C., Nutman, T., Malik, A., Roberts, C.,
et al. (1992). Naturally acquired CD8+ cytotoxic T lymphocytes against the
Plasmodium falciparum circumsporozoite protein. J. Immunol. 149, 966–971.
Stoute, J. A., Kester, K. E., Krzych, U., Wellde, B. T., Hall, T., White, K., et al. (1998).
Long-term efficacy and immune responses following immunization with the
RTS,S malaria vaccine. J. Infect. Dis. 178, 1139–1144. doi: 10.1086/515657
Tsuji, M., Mattei, D., Nussenzweig, R. S., Eichinger, D., and Zavala, F. (1994).
Demonstration of heat-shock protein 70 in the sporozoite stage of malaria
parasites. Parasitol. Res. 80, 16–21. doi: 10.1007/BF00932618
Valencia-Hernandez, A. M., Ng, W. Y., Ghazanfari, N., Ghilas, S., de Menezes,
M. N., Holz, L. E., et al. (2020). A natural peptide antigen within
the Plasmodium ribosomal protein RPL6 confers liver TRM cell-mediated
immunity against malaria in mice. Cell Host Microbe 27, 950–962. doi: 10.1016/
j.chom.2020.04.010
van der Most, R. G., Murali-Krishna, K., Lanier, J. G., Wherry, E. J., Puglielli, M. T.,
Blattman, J. N., et al. (2003). Changing immunodominance patterns in antiviral
CD8 T-cell responses after loss of epitope presentation or chronic antigenic
stimulation. Virology 315, 93–102. doi: 10.1016/j.virol.2003.07.001
van Dijk, M. R., Waters, A. P., and Janse, C. J. (1995). Stable transfection of malaria
parasite blood stages. Science 268, 1358–1362. doi: 10.1126/science.7761856
Vanderberg, J. P. (1975). Development of infectivity by the Plasmodium berghei
sporozoite. J. Para-Sitol. 61, 43–50. doi: 10.2307/3279102
Weiss, W. R., and Jiang, C. G. (2012). Protective CD8+ T lymphocytes in primates
immunized with malaria sporozoites. PLoS One 7:e31247. doi: 10.1371/journal.
pone.0031247
Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H., and Good, M. F.
(1988). CD8+ T cells (cytotoxic/suppressors) are required for protection in mice
immunized with malaria sporozoites. Proc. Natl. Acad. Sci. U.S.A. 85, 573–576.
doi: 10.1073/pnas.85.2.573
World Health Organisation (2020). World Malaria Report 2020. Geneva: World
Health Organisation.
Yoshida, N., Nussenzweig, R. S., Potocnjak, P., Nussenzweig, V., and Aikawa,
M. (1980). Hybridoma produces protective antibodies directed against the
sporozoite stage of malaria parasite. Science 207, 71–73. doi: 10.1126/science.
6985745
Zavala, F., Cochrane, A. H., Nardin, E. H., Nussenzweig, R. S., and Nussenzweig,
V. (1983). Circumsporozoite proteins of malaria parasites contain a single
immunodominant region with two or more identical epitopes. J. Exp. Med. 157,
1947–1957. doi: 10.1084/jem.157.6.1947
Zavala, F., Masuda, A., Graves, P. M., Nussenzweig, V., and Nussenzweig,
R. S. (1985). Ubiquity of the repetitive epitope of the CS protein
in different isolates of human malaria parasites. J. Immunol. 135,
2790–2793.
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2021 Hon, Friesen, Ingmundson, Scheppan, Hafalla, Müller and
Matuschewski. This is an open-access article distributed under the terms of
the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s)
and the copyright owner(s) are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Microbiology | www.frontiersin.org 13 August 2021 | Volume 12 | Article 703804
